Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R Zeeberg

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Receptor|January 1, 1995
Comparison of the in vivo rat brain regional pharmacokinetics of [3H]QNB, (R,S)-[125I]-4IQNB, and (R,R)-[125I]-4IQNB binding to the muscarinic acetylcholine receptor in relationship to the regional subtype compositionS F Boulay, M S Gitler, V K Sood, et al.
Nuclear Medicine and Biology|April 1, 1996
Specific binding component of the "inactive" stereoisomer (S,S)-[125I] IQNB to rat brain muscarinic receptors in vivoS F Boulay, R C McRee, V I Cohen, et al.
Brain Research|July 5, 1991
In vivo dissociation kinetics of [3H]quinuclidinyl benzilate: relationship to muscarinic receptor concentration and in vitro kineticsR E Gibson, B R Zeeberg, J M Melograna, et al.
Life Sciences|January 1, 1993
A novel muscarinic receptor ligand which penetrates the blood brain barrier and displays in vivo selectivity for the m2 subtypeM S Gitler, V I Cohen, R De la Cruz, et al.
Brain Research|July 31, 1995
Characterization of in vivo brain muscarinic acetylcholine receptor subtype selectivity by competition studies against (R,S)-[125I]IQNBM S Gitler, S F Boulay, V K Sood, et al.
Receptors & Signal Transduction|January 1, 1997
In vivo autoradiographic competition studies of isomers of [125I]IQNP against QNB demonstrating in vivo m2 muscarinic subtype selectivity for QNBB R Zeeberg, S F Boulay, V K Sood, et al.
Brain Research|April 13, 2000
In vitro and in vivo m2 muscarinic subtype selectivity of some dibenzodiazepinones and pyridobenzodiazepinonesV I Cohen, B Jin, R C McRee, et al.
Neuroimage|September 1, 1995
Autoradiographic evidence that quinuclidinyl 4-(bromophenyl)-2-thienylglycolate (QBPTG) displays in vivo selectivity for the muscarinic m2 subtypeS F Boulay, V K Sood, M R Rayeq, et al.
Journal of Molecular Neuroscience : MN|November 25, 1998
In vivo competition studies of Z-(-,-)-[125I]IQNP against 3-quinuclidinyl 2-(5-bromothienyl)-2-thienylglycolate (BrQNT) demonstrating in vivo m2 muscarinic subtype selectivity for BrQNTV I Cohen, B R Zeeberg, S F Boulay, et al.
Neuroimage|March 1, 1995
Autoradiographic evidence that QNB displays in vivo selectivity for the m2 subtypeR C McRee, S F Boulay, V K Sood, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Receptor|January 1, 1995
Comparison of the in vivo rat brain regional pharmacokinetics of [3H]QNB, (R,S)-[125I]-4IQNB, and (R,R)-[125I]-4IQNB binding to the muscarinic acetylcholine receptor in relationship to the regional subtype compositionS F Boulay, M S Gitler, V K Sood, et al.
Nuclear Medicine and Biology|April 1, 1996
Specific binding component of the "inactive" stereoisomer (S,S)-[125I] IQNB to rat brain muscarinic receptors in vivoS F Boulay, R C McRee, V I Cohen, et al.
Brain Research|July 5, 1991
In vivo dissociation kinetics of [3H]quinuclidinyl benzilate: relationship to muscarinic receptor concentration and in vitro kineticsR E Gibson, B R Zeeberg, J M Melograna, et al.
Life Sciences|January 1, 1993
A novel muscarinic receptor ligand which penetrates the blood brain barrier and displays in vivo selectivity for the m2 subtypeM S Gitler, V I Cohen, R De la Cruz, et al.
Brain Research|July 31, 1995
Characterization of in vivo brain muscarinic acetylcholine receptor subtype selectivity by competition studies against (R,S)-[125I]IQNBM S Gitler, S F Boulay, V K Sood, et al.
Receptors & Signal Transduction|January 1, 1997
In vivo autoradiographic competition studies of isomers of [125I]IQNP against QNB demonstrating in vivo m2 muscarinic subtype selectivity for QNBB R Zeeberg, S F Boulay, V K Sood, et al.
Brain Research|April 13, 2000
In vitro and in vivo m2 muscarinic subtype selectivity of some dibenzodiazepinones and pyridobenzodiazepinonesV I Cohen, B Jin, R C McRee, et al.
Neuroimage|September 1, 1995
Autoradiographic evidence that quinuclidinyl 4-(bromophenyl)-2-thienylglycolate (QBPTG) displays in vivo selectivity for the muscarinic m2 subtypeS F Boulay, V K Sood, M R Rayeq, et al.
Journal of Molecular Neuroscience : MN|November 25, 1998
In vivo competition studies of Z-(-,-)-[125I]IQNP against 3-quinuclidinyl 2-(5-bromothienyl)-2-thienylglycolate (BrQNT) demonstrating in vivo m2 muscarinic subtype selectivity for BrQNTV I Cohen, B R Zeeberg, S F Boulay, et al.
Neuroimage|March 1, 1995
Autoradiographic evidence that QNB displays in vivo selectivity for the m2 subtypeR C McRee, S F Boulay, V K Sood, et al.
Pageof 5